Medical Letter on the CDC & FDA
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC & FDA
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Aspergillosis
Scoring system developed to help predict risk of invasive aspergillosis
July 24th, 2005
A scoring system has been developed to help predict the risk of invasive aspergillosis. According to recent research from Spain, "The increase in the immunocompromised population and the incidence of invasive aspergillosis (IA) are leading to an overinterpretation of the potential clinical significance of many isolates of Aspergillus fumigatus. "Our work prospectively assesses the workload of the isolation of A. fumigatus and its clinical significance in the microbiology laboratory of a large teaching hospital." "During a 3-year period," wrote E. Bouza and colleagues at the University of Complutense in Madrid, "all...
Source: Medical Letter on the CDC & FDA (2005-07-24)
|
